GlassScriptPhysician profile
Todd W Ussery
NPI 1982601290
$1,616.17
in general payments reported to CMS, 2019-2025
25 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $390 · 2021: $264 · 2022: $278 · 2023: $329 · 2024: $87.60 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $208.86 | 2020-2025 | Belbuca, Xtampza |
| Stimwave Technologies Incorporated | $202.63 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $193.86 | 2019-2025 | Ztlido |
| Nevro Corp. | $125.68 | 2020-2023 | Senza |
| Abbvie INC. | $95.91 | 2021-2023 | Ubrelvy, Qulipta |
| Averitas Pharma INC. | $79.94 | 2023 | Qutenza |
| Medtronic, INC. | $79.48 | 2021-2022 | |
| Pfizer INC. | $79.34 | 2019-2021 | |
| Grt US Holding, INC. | $73.46 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.50 | 2019-2022 | |
| Abbott Laboratories | $53.31 | 2022-2025 | Eterna |
| Medtronic USA, INC. | $49.08 | 2020 | |
| Arbor Pharmaceuticals, INC. | $41.63 | 2019-2021 | |
| Fidia Pharma USA INC. | $37.08 | 2020-2025 | Hymovis, Triluron |
| Azurity Pharmaceuticals, INC. | $35.66 | 2023-2024 | Horizant, Horizant |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $34.93 | 2025 | Wavewriter Alpha Prime 16 |
| Virtus Pharmaceuticals LLC | $31.83 | 2021 | |
| Biodelivery Sciences International, INC. | $27.02 | 2020-2021 | |
| Nalu Medical, INC. | $21.97 | 2023 | Nalu Neurostimulation System |
| Assertio Therapeutics, INC. | $17.93 | 2019 | |
| Orthogenrx INC. | $16.78 | 2019 | |
| Pacira Therapeutics, INC. | $16.21 | 2019 | |
| Almatica Pharma LLC | $15.02 | 2021 | |
| Orthofix Medical, INC. | $14.02 | 2021 | |
| Mdd US Operations, LLC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Ussery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.